Table of contents
- VDR gene polymorphisms are associated with the increased susceptibility to COVID-19 among iranian population: A case-control study
- References
- Vitamin D Life -
36 studies in both categories Virus and Vitamin D Receptor - Vitamin D Life -
6 studies in both categories Virus and Vitamin D Binding Protein VDR gene polymorphisms are associated with the increased susceptibility to COVID-19 among iranian population: A case-control study
Int J Immunogenet. 2022 Jul 21. doi: 10.1111/iji.12585 PDF costs $10 to rent
Ali Jafarpoor 1, Seyed Mohammad Jazayeri 1 2, Farah Bokharaei-Salim 3, Angila Ataei-Pirkooh 3, Azam Ghaziasadi 1 2, Saber Soltani 1, Ahmadreza Sadeghi 1 4, Shima Sadeghipoor Marvi 1, Vahdat Poortahmasebi 1 5, Seyed Mahmood Seyed Khorrami 6, Mandana Hasanzad 6 7, Negar Parsania 6, Sina Nagozir 6, Narges Mokhtari 6, Ali Parsania 6, Asma Bahrami 6, Mohammad Hossein Nadjarha 6, Reza Pakzad 8, Masoud Parsania 1 9Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the pathogenesis is unclear. Host genetic background is one of the main factors influencing the patients' susceptibility to several viral infectious diseases. This study aimed to investigate the association between host genetic polymorphisms of two genes, including vitamin D receptor (VDR) and vitamin D binding protein (DBP), and susceptibility to COVID-19 in a sample of the Iranian population. This case-control study enrolled 188 hospitalized COVID-19 patients as the case group and 218 suspected COVID-19 patients with mild signs as the control group. The VDR(rs7975232, rs731236 and rs2228570) and DBP (rs7041) gene single nucleotide polymorphisms (SNPs) were genotyped by Polymerase Chain Reaction Restriction - Fragment Length Polymorphism (PCR-RFLP) method. A significant association between rs2228570 SNP in the VDR gene and the susceptibility of COVID-19 was found between case and control groups.
The CT genotype (Heterozygous) of rs2228570 C > T polymorphism showed significant association with a 3.088 fold increased odds of COVID-19 (p < .0001; adjusted OR: 3.088; 95% CI: 1.902-5.012).
In addition, a significant association between CC genotype of rs2228570 CT polymorphism and increased odds of COVID-19 in male and female groups (p = .001; adjusted OR: 3.125; 95% CI: 1.630-5.991 and p = .002; adjusted OR: 3.071; 95% CI: 1.485-6.354 respectively) were determined.
Our results revealed no significant differences in the frequency of genotype and allele of VDR (rs7975232 and rs731236) and DBP (rs7041) between SARS-CoV-2-infected patients and controls (p > .05). Our results showed that polymorphism of VDR (rs2228570) probably could influence individual susceptibility to COVID-19. The polymorphisms of VDR (rs7975232 and rs731236) and DBP (rs7041) were not associated with SARS-CoV-2 infection susceptibility.References
- AlSafar, H., Grant, W. B., Hijazi, R., Uddin, M., Alkaabi, N., Tay, G., & Al Anouti, F. (2021). COVID-19 disease severity and death in relation to vitamin D status among SARS-CoV-2-positive UAE residents. Nutrients, 13(5), 1714. Retrieved from https://doi.org/10.3390/nu13051714
- Alshahawey, M. (2021). A genetic insight into vitamin D binding protein and COVID-19. Medical Hypotheses, 149, 110531-110531. https://doi.org/10.1016/j.mehy.2021.110531
- Arai, H., Miyamoto, K.-I., Taketani, Y., Yamamoto, H., Iemori, Y., Morita, K., Tonai, T., Nishisho, T., Mori, S., & Takeda, E. (1997). A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. Journal of Bone and Mineral Research, 12(6), 915-921. https://doi.org/10.1359/jbmr.1997.12.6.915
- Bahrami, A., Parsania, M., Pourfathollah, A. A., Haghighat, S., & Sharifi, Z. (2020). Association of VDR (rs2228570, rs731236, rs7975232, rs1544410) and DBP (rs7041) genes polymorphisms with chronicity of hepatitis B in Iranian patients. Gene Reports, 19, 100615. https://doi.org/10.1016/j.genrep.2020.100615
- Blackwell, J. M., Jamieson, S. E., & Burgner, D. (2009). HLA and infectious diseases. Clinical Microbiology Reviews, 22(2), 370-385. Table of Contents. https://doi.org/10.1128/CMR.00048-08
- Bouillon, R., Schuit, F., Antonio, L., & Rastinejad, F. (2019). Vitamin D binding protein: A historic overview. Frontiers in Endocrinology (Lausanne), 10, 910. https://doi.org/10.3389/fendo.2019.00910
- Bui, L., Zhu, Z., Hawkins, S., Cortez-Resendiz, A., & Bellon, A. (2021). Vitamin D regulation of the immune system and its implications for COVID-19: A mini review. SAGE Open Medicine, 9, 205031212110140. https://doi.org/10.1177/20503121211014073
- Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418-423. https://doi.org/10.1002/jmv.25681
- Demir, M., Demir, F., & Aygun, H. (2021). Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease. Journal of Medical Virology, 93(5), 2992-2999. https://doi.org/10.1002/jmv.26832
- Dendrou, C. A., Petersen, J., Rossjohn, J., & Fugger, L. (2018). HLA variation and disease. Nature Reviews Immunology, 18(5), 325-339. https://doi.org/10.1038/nri.2017.143
- Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients, 12(4), 988. https://doi.org/10.3390/nu12040988
- Greiller, C. L., & Martineau, A. R. (2015). Modulation of the immune response to respiratory viruses by vitamin D. Nutrients, 7(6), 4240-4270. https://doi.org/10.3390/nu7064240
- Hashemi, S. M. A., Thijssen, M., Hosseini, S. Y., Tabarraei, A., Pourkarim, M. R., & Sarvari, J. (2021). Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Archives of Virology, 166(8), 2089-2108. https://doi.org/10.1007/s00705-021-05070-6
- Heidari Nia, M., Rokni, M., Mirinejad, S., Kargar, M., Rahdar, S., Sargazi, S., & Saravani, R. (2022). Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: A case-control study and in silico analyses. Journal of Medical Virology, 94(4), 1502-1512. https://doi.org/10.1002/jmv.27477
- Heshmat, R., Mohammad, K., Majdzadeh, S. R., Forouzanfar, M. H., Bahrami, A., Omrani, G. H. R., Nabipour, I., Rajabian, R., Hossein-Nezhad, A., Rezaei Hemami, M., Keshtkar, A. A., & Pajouhi, M. (1970). Vitamin D deficiency in Iran: A multi-center study among different urban areas. Iranian Journal of Public Health, 37(Supple 2), Retrieved from https://ijph.tums.ac.ir/index.php/ijph/article/view/2901
- Hill, A. V. (2006). Aspects of genetic susceptibility to human infectious diseases. Annual Review of Genetics, 40, 469-486. https://doi.org/10.1146/annurev.genet.40.110405.090546
- Batur, L. K., & Hekim, N. (2021). The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate. Journal of Medical Virology, 93(3), 1409-1413. https://doi.org/10.1002/jmv.26409
- Kazemi, S. M., Esmaieli-bandboni, A., Veisi Malekshahi, Z., Shahbaz Sardood, M., Hashemi, M., Majidzadeh, K., & Negahdari, B. (2022). Vitamin D receptor gene polymorphisms and risk of breast cancer in Iranian women. Annals of Medicine and Surgery, 73, 103150. https://doi.org/10.1016/j.amsu.2021.103150
- Lafi, Z. M., Irshaid, Y. M., El-Khateeb, M., Ajlouni, K. M., & Hyassat, D. (2015). Association of rs7041 and rs4588 polymorphisms of the vitamin D binding protein and the rs10741657 polymorphism of CYP2R1 with vitamin D status among Jordanian patients. Genetic Testing and Molecular Biomarkers, 19(11), 629-636. https://doi.org/10.1089/gtmb.2015.0058
- Laplana, M., Royo, J. L., & Fibla, J. (2018). Vitamin D receptor polymorphisms and risk of enveloped virus infection: A meta-analysis. Gene, 678, 384-394. https://doi.org/10.1016/j.gene.2018.08.017
- Luong, K. v. q. ?c, & Nguy?n, L. T. H. (2013). Beneficial role of vitamin D3 in the prevention of certain respiratory diseases. Therapeutic Advances in Respiratory Disease, 7(6), 327-350. https://doi.org/10.1177/1753465813503029
- Martins, D., Matos, G. C., Loiola, R. S., D'Annibale, V., & Corvelo, T. (2018). Relationship of vitamin D receptor gene polymorphisms in Helicobacter pylori gastric patients. Clinical and Experimental Gastroenterology, 11, 19-27. https://doi.org/10.2147/CEG.S143332
- Mashayekhi, S., Saberi, A., Salehi, Z., Biazar, G., & Mehrdel, R. (2018). VDR and GC gene polymorphisms modulate the risk of lumbar disc degeneration in Iran. Clinical Neurology and Neurosurgery, 165, 67-71. https://doi.org/10.1016/j.clineuro.2017.12.024
- Mohammadi, Z., Keshtkar, A., Fayyazbakhsh, F., Ebrahimi, M., Amoli, M. M., Ghorbani, M., Khashayar, P., Dini, M., Ebrahimi-Rad, M., & Larijani, B. (2015). Prevalence of osteoporosis and vitamin D receptor gene polymorphisms (FokI) in an Iranian general population based study (Kurdistan) (IMOS). Medical Journal of The Islamic Republic of Iran, 29, 238.
- Naderi, N., Farnood, A., Habibi, M., Derakhshan, F., Balaii, H., Motahari, Z., Agah, M. R., Firouzi, F., Rad, M. G., Aghazadeh, R., Zojaji, H., & Zali, M. R. (2008). Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology, 23(12), 1816-1822. https://doi.org/10.1111/j.1440-1746.2008.05525.x
- Parsania, A., Pouriayevali, M. H., Parsania, M., & Ghorbani, M. (2021). Chelidonium majus L. alkaloid extract enhances TRAIL-induced apoptosis in HeLa cell line through death receptors 4 and 5 upregulation. Gene Reports, 25, 101311. https://doi.org/10.1016/j.genrep.2021.101311
- Randolph, A. G., Yip, W. K., Falkenstein-Hagander, K., Weiss, S. T., Janssen, R., Keisling, S., & Bont, L. (2014). Vitamin D-binding protein haplotype is associated with hospitalization for RSV bronchiolitis. Clinical and Experimental Allergy, 44(2), 231-237. https://doi.org/10.1111/cea.12247
- Salimi, S., Eskandari, F., Rezaei, M., & Sandoughi, M. (2019). Vitamin D receptor rs2228570 and rs731236 polymorphisms are susceptible factors for systemic lupus erythematosus. Advanced Biomedical Research, 8, 48-48. https://doi.org/10.4103/abr.abr_19_19
- Sargazi, S., Sheervalilou, R., Rokni, M., Shirvaliloo, M., Shahraki, O., & Rezaei, N. (2021). The role of autophagy in controlling SARS-CoV-2 infection: An overview on virophagy-mediated molecular drug targets. Cell Biology International, 45(8), 1599-1612. https://doi.org/10.1002/cbin.11609
- Shah Alam, M., Czajkowsky, D. M., Aminul Islam, M. d., & Ataur Rahman, M. d. (2021). The role of vitamin D in reducing SARS-CoV-2 infection: An update. International Immunopharmacology, 97, 107686. https://doi.org/10.1016/j.intimp.2021.107686
- Sheervalilou, R., Ahmadzadeh, J., Alavi, S., Mobaraki, K., Sargazi, S., Shirvaliloo, M., Golchin, A., Yekanlou, A., & Mehranfar, S. (2021). Evaluation of diagnostic modalities for SARS-Cov-2: A review study. International Journal of Epidemiologic Research, 8(3), 129-137. https://doi.org/10.34172/ijer.2021.24
- Sheervalilou, R., Shirvaliloo, M., Sargazi, S., Bahari, S., Saravani, R., Shahraki, J., Shirvalilou, S., Shahraki, O., Nazarlou, Z., Shams, Z., & Ghaznavi, H. (2022). Convalescent blood: Current perspective on the efficacy of a legacy approach in COVID-19 treatment. Blood Purification, 51(1), 1-14. https://doi.org/10.1159/000513164
- Sheervalilou, R., Shirvaliloo, M., Sargazi, S., Shirvalilou, S., Shahraki, O., Pilehvar-Soltanahmadi, Y., Sarhadi, A., Nazarlou, Z., Ghaznavi, H., & Khoei, S. (2021). Application of nanobiotechnology for early diagnosis of SARS-CoV-2 infection in the COVID-19 pandemic. Applied Microbiology and Biotechnology, 105(7), 2615-2624. https://doi.org/10.1007/s00253-021-11197-y
- Soroush, N., Radfar, M., Hamidi, A. K., Abdollahi, M., Qorbani, M., Razi, F., Esfahani, E. N., & Amoli, M. M. (2017). Vitamin D receptor gene FokI variant in diabetic foot ulcer and its relation with oxidative stress. Gene, 599, 87-91. https://doi.org/10.1016/j.gene.2016.11.012
- Sutaria, N., Liu, C. T., & Chen, T. C. (2014). Vitamin D status, receptor gene polymorphisms, and supplementation on tuberculosis: A systematic review of case-control studies and randomized controlled trials. Journal of Clinical and Translational Endocrinology, 1(4), 151-160. https://doi.org/10.1016/j.jcte.2014.08.001
- Tabrizi, R., Moosazadeh, M., Akbari, M., Dabbaghmanesh, M. H., Mohamadkhani, M., Asemi, Z., & Lankarani, K. B. (2018). High prevalence of vitamin D deficiency among Iranian population: A systematic review and meta-analysis. Iranian Journal of Medical Sciences, 43(2), 125-139. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29749981, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936844
- Triantos, C., Aggeletopoulou, I., Kalafateli, M., Spantidea, P. I., Vourli, G., Diamantopoulou, G., & Thomopoulos, K. (2018). Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis. Science Reports, 8(1), 14065. https://doi.org/10.1038/s41598-018-32482-3
- Uitterlinden, A. G., Fang, Y., Van Meurs, J. B., Pols, H. A., & Van Leeuwen, J. P. (2004). Genetics and biology of vitamin D receptor polymorphisms. Gene, 338(2), 143-156. https://doi.org/10.1016/j.gene.2004.05.014
- Vatandost, S., Jahani, M., Afshari, A., Amiri, M. R., Heidarimoghadam, R., & Mohammadi, Y. (2018). Prevalence of vitamin D deficiency in Iran: A systematic review and meta-analysis. Nutrition and Health, 24(4), 269-278. https://doi.org/10.1177/0260106018802968
- Weir, E. K., Thenappan, T., Bhargava, M., & Chen, Y. (2020). Does vitamin D deficiency increase the severity of COVID-19? Clinical Medicine (London, England), 20(4), e107-e108. https://doi.org/10.7861/clinmed.2020-0301
- Zarrin, R., Bagheri, M., Mehdizadeh, A., Ayremlou, P., & Faghfouri, A. H. (2018). The association of FokI and ApaI polymorphisms in vitamin D receptor gene with autoimmune thyroid diseases in the northwest of Iran. Medical Journal of the Islamic Republic of Iran, 32, 18. https://doi.org/10.14196/mjiri.32.4
- Zhou, P., Yang, X. -L., Wang, X. -G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., …Zheng, X.-S. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270-273. https://doi.org/10.1038/s41586-020-2012-7
Vitamin D Life -
36 studies in both categories Virus and Vitamin D Receptor This list is automatically updated
- COVID maximum downregulation of Vitamin D receptor and CYP27B1 resulted in death - Feb 2024
- COVID in hospital stopped by Vitamin D Receptor activators (curcumin, quercetin) – RCT June 2023
- Children with COVID 4X more likely to have poor Vitamin D Receptors (Note: COVID deactivates VDR) – April 2023
- Diabetes 3X more likely if had COVID ICU (VDR was deactivated) - April 2023
- COVID variants protect themselves by deactivating different VDR variants– March 2023
- Dengue Fever decimated by Vitamin D - many studies
- COVID kids were more likely to have a poor VDR (4.3 X), than low Vitamin D (2.6 X) – Sept 2022
- Cancers are associated with low vitamin D, poor vaccination response and perhaps poor VDR – July 2022
- COVID 3X more likely if a poor Receptor (cells get less Vitamin D from the blood) – July 2022
- Long-COVID is now the biggest COVID concern - many studies
- COVID death 12X more likely if poor Vitamin D Receptor (less D gets to cells) - many studies
- COVID severity, ICU, and mortality all associated with poor vitamin D receptor (but not D, everyone had low D) -Dec 2021
- Different Vitamin D Receptor problems cause different COVID problems - Dec 2021
- COVID-19 severity associated with 3 vitamin D genes – Oct 2021
- Poor Vitamin D receptor blocked Vitamin D from fighting avian influenza viruses (in mice) – July 2021
- Epstein-Barr is yet another virus that deactivates the Vitamin D receptor (COVID later suspected as well)– 2010
- COVID-19 symptoms and comorbidities associated with the type of Vitamin D Receptor – Oct 2021
- Enveloped virus infection (RSV, coronavirus, HIV, etc.) 1.5X more likely if poor Vitamin D Receptor – meta-analysis Dec 2018
- COVID-19 outpatients getting Quercetin nanoemulsion had excellent outcomes (Q increased Vitamin D in cells) – RCT – June 2021
- A virus that most adults have (Cytomegalovirus) decreases the amount of Vitamin D which gets to the cells – Jan 2017
- COVID virus alters the activation of 100 vitamin D related genes in the lung – April 2021
- Common sense COVID-19 risk reduction - masks, social distancing, vitamin D - Oct 2020
- AI is examining 170,000 potential COVID-19 treatments, Vitamin D is one of only 6 found – Sept 4, 2020
- Vitamin D Receptor activation should reduce ARDS associated with COVID-19 - June 2020
- Dengue viral production decreased 1000X if activate Vitamin D Receptor (in lab) – July 2020
- Vitamin D, Quercetin, and Estradiol all increase vitamin D in cells and increase genes which reduce COVID-19 – May 21, 2020
- Quercetin and Vitamin D - Allies Against COVID-19
- Risk of enveloped virus infection is increased 50 percent if poor Vitamin D Receptor - meta-analysis Dec 2018
- Hand, foot, and Mouth disease is 14X more likely if poor Vitamin D Receptor – Oct 2019
- Treating herpes reduced incidence of senile dementia by 10 X (HSV1 reduces VDR by 8X) – 2018
- Severe hand, foot, and mouth virus is 2.9 X more likely if poor Vitamin D receptor – Oct 2018
- Hepatitis B virus reduced by 5X the Vitamin D getting to liver cells in the lab – Oct 2018
- Some enveloped virus are 1.2 X more likely if have a poor Vitamin D Receptor -Aug 2018
- Severe Pertussis is 1.5 times more likely if poor vitamin D receptor – Feb 2016
- Dengue Fever associated with poor vitamin D receptor – July 2002
- Dengue virus 2X to 4X more likely if vitamin D receptor gene problems
Vitamin D Life -
6 studies in both categories Virus and Vitamin D Binding Protein This list is automatically updated
- Some COVID hospitalizations are due to poor Vitamin D genes (Binding Protein in this commentary) – June 2022
- COVID-19 severity associated with 3 vitamin D genes – Oct 2021
- COVID virus alters the activation of 100 vitamin D related genes in the lung – April 2021
- Hypothesis: Poor Vitamin D Binding protein may increase COVID-19 risk - March 6, 2021
- Another gene which limits Vitamin D is found to increase COViD-19 (Binding Protein in this case) Aug 8, 2020
- Meningitis and other brain infections should be prevented by Vitamin D – June 2014
COVID 3X more likely if a poor Receptor (cells get less Vitamin D from the blood) – July 2022968 visitors, last modified 21 Jul, 2022, This page is in the following categories (# of items in each category) - Vitamin D Life -